04-24-2020, 10:53 PM
We have a COVID tracker at work (unfortunately internal or I would share). There's an automatic literature search that they run through and curate. Right now it is generating about 1000 articles a week. Most of them they can dismiss out of hand; they probably narrow it down to a couple of dozen "interesting" articles, and create a digest summarizing a handful.
I was already getting the New England Journal, JAMA, and a couple pulmonary journals TOCs and "recently accepted articles". They all have started sending dedicated COVID updates.
I also get the FiercePharma newsletter, as it tracks industry trends.
I'll echo chrisk on the WSJ. It's expensive and but I get an electronic subscription through work, and it is high quality.
NYTimes has made most of their COVID-19 coverage free.
The Economist is always a great value. I paid for a three year subscription last year, and it is worth every penny.
On my near daily walks (used to be on my commutes), I listen to podcasts: NPR's Up First, the 10 min NPR news digest, Marketplace, more Economist, and the fivethirtyeight politics podcast. I don't get through everything, but I can stand listening at 1.5x speed.
BC
I was already getting the New England Journal, JAMA, and a couple pulmonary journals TOCs and "recently accepted articles". They all have started sending dedicated COVID updates.
I also get the FiercePharma newsletter, as it tracks industry trends.
I'll echo chrisk on the WSJ. It's expensive and but I get an electronic subscription through work, and it is high quality.
NYTimes has made most of their COVID-19 coverage free.
The Economist is always a great value. I paid for a three year subscription last year, and it is worth every penny.
On my near daily walks (used to be on my commutes), I listen to podcasts: NPR's Up First, the 10 min NPR news digest, Marketplace, more Economist, and the fivethirtyeight politics podcast. I don't get through everything, but I can stand listening at 1.5x speed.
BC